Physiologically Based Pharmacokinetic Modeling for Substitutability Analysis of Venlafaxine Hydrochloride Extended-Release Formulations Using Different Release Mechanisms: Osmotic Pump Versus Openable Matrix-Reference-Cited by-同舟云学术

Physiologically Based Pharmacokinetic Modeling for Substitutability Analysis of Venlafaxine Hydrochloride Extended-Release Formulations Using Different Release Mechanisms: Osmotic Pump Versus Openable Matrix

Published:2016-10 Issue:10 Volume:105 Page:3088-3096
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Lin Ho-Pi,Sun Dajun,Zhang Xinyuan,Wen Hong

Funder

Oak Ridge Institute for Science

U.S. Department of Energy

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Introduction and an Overview of Oral Controlled Release Formulation Design;Wen,2010

2. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems;Huang;J Control Release,2001

3. Oral controlled release formulation for highly water-soluble drugs: drug–sodium alginate–xanthan gum–zinc acetate matrix;Zeng;Drug Dev Ind Pharm,2004

4. Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum;Gohel;AAPS PharmSciTech,2009

5. Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet;Aboelwafa;AAPS PharmSciTech,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Targeting of Venlafaxine via Intranasal Transbilosomes Thermogel for Improved Management of Depressive Disorder;Journal of Pharmaceutical Sciences;2024-08

2. Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms;Pharmaceutical Research;2024-03-05

3. Precision dosing of venlafaxine during pregnancy: a pharmacokinetics modelling approach;Journal of Pharmacy and Pharmacology;2023-12-23

4. In Silico Modeling Approaches Coupled with In Vitro Characterization in Predicting In Vivo Performance of Drug Delivery System Formulations;Molecular Pharmaceutics;2023-07-31

5. Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline;Pharmaceutics;2023-03-09